Opendata, web and dolomites

Bio-LP-1

Bio-LP-1 - A novel technology for water safety and surveillance testing

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "Bio-LP-1" data sheet

The following table provides information about the project.

Coordinator
BIOPROBE DIAGNOSTICS LIMITED 

Organization address
address: FAIRWINDS BALLINACOURTY DUNGARVAN
city: CO WATERFORD
postcode: n.a.
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Project website https://bioprobedx.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-06-01   to  2018-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BIOPROBE DIAGNOSTICS LIMITED IE (CO WATERFORD) coordinator 50˙000.00

Map

 Project objective

In Europe, contaminated water, water distribution and premise plumbing systems are a significant source of many of Health Care Associated Infections, and pose a significant threat to human health. Legionaires Disease, which is spread through contaminated water particles, is estimated to cause 180–360 cases per million inhabitants in Europe alone with mortality rates ranging from 10-25%.

It is estimated that the global legionella testing market will reach $352.6 million by 2025, with water testing the largest testing type segment in terms of revenue, due to increased water testing activities in various industries as a preventive measure to control infections. Current gold standard tests (bacterial culture-based) used to detect Legionella species are slow and lack sensitivity. These are unsatisfactory, and have many limitations affecting results seen, and have an onward impact on human health.

BioProbe Diagnostics (BPD), is a recently established Irish diagnostics company, specialising in the detection of environmental pathogens (http://bioprobedx.com/). We have developed a novel rapid single test kit (Bio-LP-1) to address the current limitations and unmet Legionella testing market needs. Bio-LP-1 allows for the rapid (< 5 hr), quantitative, simultaneous and identification of Legionella species, Legionella pneumophilla and Lp-sg1 in water, allowing for a faster, more accurate, robust test, quickly identifying harmful water samples, with the potential to positively impact on human health. To close the gap from lab to market, BPD seeks to use this feasibility study to accredit Bio-LP-1 to ensure market acceptance. This study will also include a feasibility assessment with respect to product manufacturing and distribution supply chain. Upon completion of this feasibility study, BPD will be in a position to launch their first product to market, while also determining opportunities for company growth and development over the next 3 years.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BIO-LP-1" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BIO-LP-1" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Dyme (2019)

Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any cont

Read More  

QTB4AMR (2019)

Utilizing an innovative chemical platform to defeat antimicrobial resistance

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More